Ferozsons Laboratories Limited (PSX:FEROZ)

Market Cap	13.40B
Revenue (ttm)	16.82B
Net Income (ttm)	689.01M
Shares Out	43.47M
EPS (ttm)	15.85
PE Ratio	19.46
Forward PE	n/a
Dividend	3.00 (0.97%)
Ex-Dividend Date	Oct 18, 2024

Volume	29,668
Average Volume	110,806
Open	310.03
Previous Close	n/a
Day's Range	307.05 - 311.89
52-Week Range	217.90 - 393.00
Beta	0.55
RSI	36.79
Earnings Date	Apr 24, 2025

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,896
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2024, Ferozsons Laboratories's revenue was 15.85 billion, an increase of 38.38% compared to the previous year's 11.46 billion. Earnings were 683.15 million, an increase of 151.83%.